{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:59:15Z","timestamp":1789570755714,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.actbio.2024.08.016","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T22:48:34Z","timestamp":1723934914000},"page":"352-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Brain biodistribution of myelin nanovesicles with targeting potential for multiple sclerosis"],"prefix":"10.1016","volume":"187","author":[{"given":"Pasquale","family":"Picone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Salvatore","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8453-0804","authenticated-orcid":false,"given":"Francesco","family":"Cancilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Girgenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Cancemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6212-5154","authenticated-orcid":false,"given":"Vera","family":"Muccilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella Di","family":"Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cipollina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1420-0914","authenticated-orcid":false,"given":"Marzia","family":"Soligo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Manni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0572-3588","authenticated-orcid":false,"given":"Gianluca","family":"Sferrazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Scalisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2024.08.016_bib0001","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0022-510X(99)00143-4","article-title":"A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials","volume":"15","author":"Amato","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.actbio.2024.08.016_bib0002","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis: mechanisms and immunotherapy","volume":"97","author":"Baeche-Allan","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.actbio.2024.08.016_bib0003","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/400_2009_21","article-title":"Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis","volume":"51","author":"Weber","year":"2010","journal-title":"Results Probl. Cell Differ."},{"key":"10.1016\/j.actbio.2024.08.016_bib0004","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-065X.2011.01016.x","article-title":"Immune tolerance in multiple sclerosis","volume":"241","author":"Goverman","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.actbio.2024.08.016_bib0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/brainsci10060333","article-title":"Recent advances in antigen-specific immunotherapies for the treatment of multiple sclerosis","volume":"29","author":"Kammona","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.actbio.2024.08.016_bib0006","article-title":"Antigen-specific immune tolerance in multiple sclerosis-promising approaches and how to bring them to patients","volume":"22","author":"Lutterotti","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2024.08.016_bib0007","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1517\/14728210903203790","article-title":"Antigen-specific therapies in multiple sclerosis","volume":"14","author":"Giacomini","year":"2009","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.actbio.2024.08.016_bib0008","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2147\/NDT.S140634","article-title":"The role of microglia in multiple sclerosis","volume":"26","author":"Luo","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.actbio.2024.08.016_bib0009","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/brain\/awg107","article-title":"cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity","volume":"126","author":"Mycko","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.actbio.2024.08.016_bib0010","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","article-title":"Multiple sclerosis","volume":"391","author":"Thompson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.actbio.2024.08.016_bib0011","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.3390\/ijms22168866","article-title":"Multiple sclerosis: focus on extracellular and artificial vesicles, nanoparticles as potential therapeutic approaches","volume":"122","author":"Nuzzo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2024.08.016_bib0012","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4103\/1673-5374.346473","article-title":"Biofabrication of nanovesicles for brain diseases","volume":"18","author":"Picone","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.actbio.2024.08.016_bib0013","article-title":"Synaptosomes: new vesicles for neuronal mitochondrial transplantation","volume":"6","author":"Picone","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"4","key":"10.1016\/j.actbio.2024.08.016_bib0014","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3390\/ijms23042245","article-title":"Promising treatment for multiple sclerosis: mitochondrial transplantation","volume":"17","author":"Picone","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2024.08.016_bib0015","article-title":"Nano-structured myelin: new nanovesicles for targeted delivery to white matter and microglia, from brain-to-brain","volume":"7","author":"Picone","year":"2021","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.actbio.2024.08.016_bib0016","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1126\/science.7680493","article-title":"Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis","volume":"26","author":"Weiner","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.actbio.2024.08.016_bib0017","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00726-021-03061-0","article-title":"Meta-proteomic analysis of the Shandrin mammoth by EVA technology and high-resolution mass spectrometry: what is its gut microbiota telling us?","volume":"53","author":"Cucina","year":"2021","journal-title":"Amino Acids"},{"key":"10.1016\/j.actbio.2024.08.016_bib0018","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biomaterials.2015.11.057","article-title":"Ionizing radiation-engineered nanogels as insulin nanocarriers for the development of a new strategy for the treatment of Alzheimer's disease","volume":"80","author":"Picone","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2024.08.016_bib0019","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bbamcr.2015.01.017","article-title":"Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-\u03baB activation: use of insulin to attenuate metformin's effect","volume":"1853","author":"Picone","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.actbio.2024.08.016_bib0020","doi-asserted-by":"crossref","DOI":"10.1023\/A:1022500301494","article-title":"Characteristic composition of myelin","author":"Morell","year":"1999","journal-title":"Neurochemistry: Molecular, Cellular and Medical Aspects"},{"key":"10.1016\/j.actbio.2024.08.016_bib0021","first-page":"117","article-title":"Evaluation of biocompatibility using in vitro methods: interpretation and limitations","volume":"126","author":"Bruinink","year":"2012","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"10.1016\/j.actbio.2024.08.016_bib0022","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","article-title":"Intranasal drug delivery: opportunities and toxicologic challenges during drug development","volume":"12","author":"Keller","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.actbio.2024.08.016_bib0023","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12974-020-01899-x","article-title":"CD36-mediated uptake of myelin debris by macrophages and microglia reduces neuroinflammation","volume":"17","author":"Grajchen","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.actbio.2024.08.016_bib0024","doi-asserted-by":"crossref","first-page":"10459","DOI":"10.1016\/j.cellimm.2022.104591","article-title":"Consequences and mechanisms of myelin debris uptake and processing by cells in the central nervous system","volume":"380","author":"Hammel","year":"2022","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.actbio.2024.08.016_bib0025","doi-asserted-by":"crossref","first-page":"12904","DOI":"10.1523\/JNEUROSCI.2531-06.2006","article-title":"Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species","volume":"13","author":"Liu","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.actbio.2024.08.016_bib0026","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14573\/altex.2009.2.83","article-title":"The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation","volume":"26","author":"Henn","year":"2009","journal-title":"ALTEX"},{"key":"10.1016\/j.actbio.2024.08.016_bib0027","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jnr.490380409","article-title":"Activation of adult human derived microglia by myelin phagocytosis in vitro","volume":"38","author":"Williams","year":"1994","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.actbio.2024.08.016_bib0028","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02527713","article-title":"Receptor-mediated phagocytosis of myelin by macrophages and microglia: effect of opsonization and receptor blocking agents","volume":"21","author":"Mosley","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.actbio.2024.08.016_bib0029","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-5728(96)00110-5","article-title":"Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis","volume":"70","author":"Van der Laan","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.actbio.2024.08.016_bib0030","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/brain\/awh707","article-title":"Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis","volume":"129","author":"Boven","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.actbio.2024.08.016_bib0031","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mcn.2005.10.006","article-title":"Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem\/progenitor cells","volume":"31","author":"Butovsky","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.actbio.2024.08.016_bib0032","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.mcn.2005.03.005","article-title":"Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective","volume":"29","author":"Butovsky","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.actbio.2024.08.016_bib0033","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41419-018-0288-4","article-title":"Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis","volume":"14","author":"Rossi","year":"2018","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.actbio.2024.08.016_bib0034","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/brainsci6020018","article-title":"Neuroimmunology of the Interleukins 13 and 4","volume":"13","author":"Mori","year":"2016","journal-title":"Brain Sci."},{"key":"10.1016\/j.actbio.2024.08.016_bib0035","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.4049\/jimmunol.160.10.4822","article-title":"A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL\/6 mice and BALB\/c mice","volume":"15","author":"Falcone","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2024.08.016_bib0036","first-page":"2581","article-title":"Manganese-containing Prussian blue nanoparticles for imaging of pediatric brain tumors","volume":"23","author":"Dumont","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actbio.2024.08.016_bib0037","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1016\/j.biomaterials.2011.09.004","article-title":"Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration","volume":"32","author":"Xia","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2024.08.016_bib0038","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrn784","article-title":"New concepts in the immunopathogenesis of multiple sclerosis","volume":"3","author":"Hemmer","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.actbio.2024.08.016_bib0039","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)81107-1","article-title":"Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system","volume":"85","author":"Steinman","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2024.08.016_bib0040","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3389\/fimmu.2017.01335","article-title":"Divergent immunomodulation capacity of individual myelin peptides-components of liposomal therapeutic against multiple sclerosis","volume":"16","author":"Ivanova","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2024.08.016_bib0041","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s10753-018-0872-x","article-title":"Immunoregulatory effects of silymarin on proliferation and activation of Th1 cells isolated from newly diagnosed and IFN-\u00df1b-treated MS patients","volume":"42","author":"Navabi","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.actbio.2024.08.016_bib0042","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jneuroim.2010.09.030","article-title":"Regulation of Th1\/Th17 cytokines and IDO gene expression by inhibition of calpain in PBMCs from MS patients","volume":"232","author":"Smith","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.actbio.2024.08.016_bib0043","first-page":"284","article-title":"Modulation of TLR3\/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis","volume":"28","author":"Crowley","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.actbio.2024.08.016_bib0044","doi-asserted-by":"crossref","DOI":"10.1080\/0891693031000089427","article-title":"Evidence for cytokine dysregulation in multiple sclerosis: peripheral blood mononuclear cell production of pro-inflammatory and anti-inflammatory cytokines during relapse and remission","volume":"36","author":"Hollifield","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.actbio.2024.08.016_bib0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-065X.1989.tb00543.x","article-title":"Regulation of T-cell activation: differences among T-cell subsets","volume":"111","author":"Gajewski","year":"1989","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.actbio.2024.08.016_bib0046","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-2094-6-28","article-title":"Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta","volume":"13","author":"Sternberg","year":"2009","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.actbio.2024.08.016_bib0047","doi-asserted-by":"crossref","first-page":"137","DOI":"10.13005\/bpj\/2349","article-title":"The role of the proinflammatory and anti-inflammatory cytokines in multiple sclerosis","volume":"15","author":"Vani","year":"2022","journal-title":"Biomed. Pharmacol. J."},{"key":"10.1016\/j.actbio.2024.08.016_bib0048","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2024.08.016_bib0049","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/eji.200737984","article-title":"Nanoparticles target distinct dendritic cell populations according to their size","volume":"38","author":"Manolova","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.actbio.2024.08.016_bib0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.nano.2014.11.004","article-title":"Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro","volume":"11","author":"Fytianos","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.actbio.2024.08.016_bib0051","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2008.05.005","article-title":"Reactive oxygen species play a central role in the activity of cationic liposome based cancer vaccine","volume":"130","author":"Yan","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2024.08.016_bib0052","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41565-020-00810-2","article-title":"Inducing immune tolerance with dendritic cell-targeting nanomedicines","volume":"16","author":"Cifuentes-Rius","year":"2021","journal-title":"Nat. Nanotechnol."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706124004598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706124004598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T11:54:11Z","timestamp":1727697251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706124004598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":52,"alternative-id":["S1742706124004598"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2024.08.016","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain biodistribution of myelin nanovesicles with targeting potential for multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2024.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of Acta Materialia Inc.","name":"copyright","label":"Copyright"}]}}